Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.

导出 OA

翻译打印收藏纠错

第一作者： Stephen L,Abrams

第一单位： Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC, USA.

作者： Stephen L,Abrams ^[1] ; Peter P,Ruvolo ^[2] ; Vivian R,Ruvolo ^[2] ; Giovanni,Ligresti ^[3] ; Alberto M,Martelli ^[4] ; Lucio,Cocco ^[4] ; Stefano,Ratti ^[4] ; Agostino,Tafuri ^[5] ; Linda S,Steelman ^[1] ; Saverio,Candido ^[6] ; Massimo,Libra ^[6] ; James A,McCubrey ^[1]

作者单位： Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC, USA. ^[1] Section of Signal Transduction and Apoptosis, Hormel Institute, University of Minnesota, Austin, MN, USA.;Current/Present address: Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. ^[2] Department of Biomedical and Biotechnological Sciences, Pathology and Oncology Section, University of Catania, Catania, Italy.;Current/Present address: Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, MN, USA. ^[3] Department of Biomedical and Neuromotor Sciences, Università di Bologna, Bologna, Italy. ^[4] Hematology, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. ^[5] Department of Biomedical and Biotechnological Sciences, Pathology and Oncology Section, University of Catania, Catania, Italy. ^[6]

关键词 TP53 apoptosis chemosensitivity drug sensitivity nutlin-3a

DOI 10.18632/oncotarget.20408

PMID 29100331

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交